
Journal of Neurology, Journal Year: 2025, Volume and Issue: 272(5)
Published: April 19, 2025
Parkinson's disease (PD) is the fastest-growing neurodegenerative disorder, affecting over 8.5 million people worldwide, with symptoms that severely impact patients' quality of life. While treatments like levodopa and deep brain stimulation help manage symptoms, they require frequent adjustments have limitations. Wearable devices offer real-time monitoring motor non-motor enabling personalized treatment, but challenges related to comfort, usability, patient adherence hinder their widespread adoption. Many individuals PD experience discomfort, emotional distress, or interface difficulties, reducing long-term adherence. This study synthesizes qualitative research on experiences wearables identify key usability barriers improve device design for better clinical integration. Following Joanna Briggs Institute methodology systematic reviews, we searched PubMed, Web Science, Embase, Cochrane Library, CINAHL, CNKI, WanFang, VIP databases up March 3, 2025. Additional gray literature reference lists were examined manually. Included studies underwent comprehensive assessment, integration, analysis. Nine included, identifying four main themes eleven sub-themes. The primary physiological experience, psychological Responses, social Interaction, Expectation. meta-synthesis reveals dual role wearable in managing disease, improving autonomy control while presenting reliability, well-being. findings emphasize need personalized, context-sensitive adapt fluctuating address privacy concerns, seamlessly integrate into practice outcomes
Language: Английский